Plan B Pioneers OTC “Pharmacy Counter” Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Behind-the-counter, dual status approval breaks the hold on commissioner nominee von Eschenbach.
You may also be interested in...
Von Eschenbach Promotes Behind-The-Counter Drug Class
FDA commissioner says creation of a third regulated therapeutic class would apply to drug, biologic and device products.
Von Eschenbach Promotes Behind-The-Counter Drug Class
FDA commissioner says creation of a third regulated therapeutic class would apply to drug, biologic and device products.
White House Faces Subpoena On Plan B Communications With FDA
Suit broadened after court finds FDA acted in “bad faith.”